Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Also relevant to:Senior (65+, Medicare/SS)

Where it is in the process

Plain-English Summary

Source: OpenStates · fetched January 7, 2026

Votes

Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when NY A02289 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

RSS feed· Atom 1.0 + JSON Feed per bill
Bluesky· follow a CivicRadar bot post per status change
Telegram· channel or DM via bot
Discord· channel webhook
WhatsApp· via WhatsApp Business
SMS· via Twilio